Drug Profile
PL 37
Alternative Names: Debio 0827; IC-800; PL-37Latest Information Update: 28 Sep 2023
Price :
$50
*
At a glance
- Originator Pharmaleads
- Developer IACTA Pharmaceuticals; Pharmaleads
- Class Amines; Disulfides; Non-opioid analgesics; Small molecules
- Mechanism of Action Aminopeptidase inhibitors; Neprilysin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Neuropathic pain
- Preclinical Ocular pain
- No development reported Cancer pain; Pain; Postoperative pain
Most Recent Events
- 28 Sep 2023 No recent reports of development identified for preclinical development in Pain in France (PO)
- 28 Sep 2023 No recent reports of development identified for preclinical development in Postoperative-pain in France (IV, Injection)
- 28 Oct 2021 Preclinical trials in ocular pain in USA (Ophthalmic) before October 2021 ,